Claims data analysis showed that 60% of patients with chronic obstructive pulmonary disease (COPD) receiving triple therapy had no evidence of exacerbation or only 1 exacerbation not resulting in hospitalization.
Stephen Stemkowski, PhD
Advertisement
Articles by Stephen Stemkowski, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Trump Childhood Vaccine Order: What It Means for Parents and Payers
2
FDA Proposes GRAS Rule, Advances Ultra-Processed Food Definition
3
Cardiac Amyloidosis Diagnosis Lags After Heart Failure Onset
4
Orelabrutinib Cuts Progression Risk 68% in Frontline CLL/SLL
5